Ann: ImpediMed Achieves Critical Mass in First Key Target State, page-14

@nottawombat
I don't know. I'm more occupied with how many SOZOs are on the truck on their way to Michigan. They knew this was happening at the time of the CR, so I would anticipate lots of paperwork going on behind the scenes. Sign here please. Looking forward to a decent sales increase at the Q4 if not announced before.

@mirri11
You nailed the state & coverage


Not sure about the second director pick on first impressions, he is recently on the board of directors for 2 small fries with 1B share each outstanding, possible lifestyle gig on those ventures. Same old story of good at Rasing capital, corporate carry on etc. How about one that knows how to make money, can monitor cost controls and logistics in complex systems. Remember the first OMP purchase is to comply with been a board member approx. 45K of stock. But better if he buys 1M+ or more worth of stock. The holdings he has in the other 2 directorships aren't substantial.

I don't know what day the policy was released there is no release date on the document.
The policy was approved on the 13/06/23.
If you have a spare couple of K you can subscribe to providers that monitor for changes in polices to get a nice egde. @Steini put your profits to good use.
Maybe this was released a couple of days ago and savvy players knew or guessed before the announcement.
Either way, someone knew something on the 27/06/23 and wanted in. maybe a nice sales contract.

Its the sales that count. Let the counting begin.
Looking forward to the Q4.

Kind regards
Acclivity